Thyroid cancer
Thyroid cancer occurs when cells in your thyroid undergo genetic changes (mutations). The mutations allow the cells to grow and multiply rapidly. The cells also lose the ability to die, as normal cells would.
Showing all 7 results
-
CAPRELSA® (vandetanib) Tablets for Oral use. Initial U.S. Approval: 2011
-
COMETRIQ™ (cabozantinib) capsules, for oral use. Initial U.S. Approval: 2012
-
LENVIMA® (lenvatinib) capsules, for oral use. Initial U.S. Approval: 2015
-
NEXAVAR (sorafenib) tablets, for oral use. Initial U.S. Approval: 2005
-
NUPLAZID ™ (pimavanserin) tablets, for oral use Initial U.S. Approval: 2016
-
SORAFENAT (Sorafenib) Tablets IP for oral use.
-
TEPEZZA (teprotumumab-trbw) for injection, for intravenous use Initial U.S. Approval: 2020